(Q57903773)

English

Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer

No description defined

In more languages
default for all languages
No label defined

No description defined

Statements

Phase 2 Trial of Nonpegylated Doxorubicin (Myocet) as Second-Line Treatment in Advanced or Recurrent Endometrial Cancer (English)
0 references
0 references
0 references
Alessia Di Legge
0 references
Ilaria Nausica Trivellizzi
0 references
Maria Cristina Moruzzi
0 references
Adele Pesce
0 references
November 2011
0 references
21
0 references
8
0 references
1446-1451
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit